Literature DB >> 7553687

Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomas.

S Kudoh1, Q Wang, O F Hidalgo, P Rayman, R R Tubbs, M G Edinger, V Kolenko, J Panuto, R Bukowski, J H Finke.   

Abstract

T cells infiltrating (T-TIL) B cell non-Hodgkin's lymphomas (NHL) are thought to represent a local host response to the tumor. However, tumor progression in the presence of this T cell infiltrate suggests that the T-TIL may be functionally impaired. To address this issue we determined whether response to stimulation of T-TIL from 25 patients with NHL through the T cell receptor (TCR/CD3) and the interleukin-2 (IL-2) receptor (IL-2R) was intact, since activation of these receptors is important for proliferation and cytokine production. Our results demonstrate defects in response to stimulation via TCR/CD3 and the IL-2R in T-TIL cells from patients with NHL that were not observed with T cells from the peripheral blood. T-TIL showed minimal proliferation to anti-CD3 and only modest proliferation to IL-2 alone or when combined with anti-CD3. Moreover, cytokine production in T-TIL was impaired since stimulation through the TCR/CD3 complex did not induce mRNA for interferon gamma (IFN gamma), IL-2, IL-4 or IL-10. The functional unresponsiveness of these cells may be linked to altered signalling through the TCR/CD3 since an abnormal tyrosine phosphorylation pattern was detected in T-TIL after stimulation with anti-CD3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553687     DOI: 10.1007/bf01521344

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  36 in total

1.  The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.

Authors:  J S Weber; J C Yang; S L Topalian; D J Schwartzentruber; D E White; S A Rosenberg
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

Review 2.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

Authors:  K S Ullman; J P Northrop; C L Verweij; G R Crabtree
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.

Authors:  S M Lippman; C M Spier; T P Miller; D J Slymen; J A Rybski; T M Grogan
Journal:  Mod Pathol       Date:  1990-05       Impact factor: 7.842

4.  Correlation of cell surface antigen expression on human thymocytes by multi-color flow cytometric analysis: implications for differentiation.

Authors:  L L Lanier; J P Allison; J H Phillips
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

5.  Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. SWOG Central Repository Members.

Authors:  J Diaz; R Tubbs; M Stoler; T Grogan
Journal:  Leuk Lymphoma       Date:  1993-01

6.  Influence of T-helper cell specific monoclonal antibody on progressive growth of B-cell lymphomas in SJL/J mice: correlation of acute treatment dosage with tumor dormancy or complete remission in long-term survivors.

Authors:  R M Alisauskas; C A Friedman; N M Ponzio
Journal:  Cancer Commun       Date:  1990

7.  Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.

Authors:  L W Kwak; M J Campbell; D K Czerwinski; S Hart; R A Miller; R Levy
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

8.  Human cytotoxic T-lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion.

Authors:  S Luna-Fineman; J E Lee; P K Wesley; C Clayberger; A M Krensky
Journal:  Cancer       Date:  1992-10-15       Impact factor: 6.860

9.  In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

Authors:  P J Spiess; J C Yang; S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

10.  Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

Authors:  H Nakagomi; M Petersson; I Magnusson; C Juhlin; M Matsuda; H Mellstedt; J L Taupin; E Vivier; P Anderson; R Kiessling
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

View more
  3 in total

1.  CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.

Authors:  S Agrawal; J Marquet; M H Delfau-Larue; C Copie-Bergman; H Jouault; F Reyes; A Bensussan; J P Farcet
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

2.  Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.

Authors:  Zhi-Zhang Yang; Anne J Novak; Steven C Ziesmer; Thomas E Witzig; Stephen M Ansell
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

3.  Differences in TCR-Vβ repertoire and effector phenotype between tumor infiltrating lymphocytes and peripheral blood lymphocytes increase with age.

Authors:  Hongwei Shao; Yusheng Ou; Teng Wang; Han Shen; Fenglin Wu; Wenfeng Zhang; Changli Tao; Yin Yuan; Huaben Bo; Hui Wang; Shulin Huang
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.